Naphthimidazolyl neuropeptide Y receptor antagonists
申请人:Eli Lilly and Company
公开号:US05776931A1
公开(公告)日:1998-07-07
This invention provides a series of substituted 1H-naphth\x9b2,3-d!imidazoles which are useful in treating a condition associated with an excess of neuropeptide Y. This invention also provides methods employing these substituted 1H-naphth\x9b2,3-d!imidazoles as well as pharmaceutical formulations with comprise as an active ingredient one or more of these compounds.